Who is sponsoring NCT06241209?

NCT06241209 is sponsored by University of Alberta.

What drugs are being tested in NCT06241209?

Interventions in NCT06241209: PowerPoint program visual stimulation.

What condition does NCT06241209 study?

NCT06241209 studies Hemianopsia, Visual Field Defect, Peripheral, Visual Impairment.

Is NCT06241209 still recruiting?

NCT06241209 is currently recruiting now. Last updated 16 March 2026.

Last reviewed 2026-03-16 · How we verify

NCT06241209

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hemianopsia Rehabilitation After Stroke or Brain Injury

Recruiting now NA Last updated 16 March 2026

What this trial tests

NA trial testing PowerPoint program visual stimulation in Hemianopsia in 40 participants. Currently enrolling.

Timeline

25 January 2024

Primary endpoint
15 December 2027

15 December 2028

Quick facts

Lead sponsor	University of Alberta
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	25 January 2024
Primary completion	15 December 2027
Estimated completion	15 December 2028
Sites	1 location across Canada

Drugs / interventions tested

PowerPoint program visual stimulation

Conditions studied

Hemianopsia — all drugs for Hemianopsia →
Visual Field Defect, Peripheral — all drugs for Visual Field Defect, Peripheral →
Visual Impairment — all drugs for Visual Impairment →

Sponsor

University of Alberta

Who can join

18 and older, any sex, with Hemianopsia or Visual Field Defect, Peripheral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In patients with hemianopsia following stroke or brain injury, we will determine if stimulating the visual field with images from a PowerPoint slide set can increase the visual field.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hemianopsia

Currently open trials in the same condition.

NCT05141604 — Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking · NA · active not recruiting

Other University of Alberta trials

Trials by the same sponsor.

NCT03240900 — Electrical Stimulation for Improving Postoperative Breast Sensation · NA · not yet recruiting
NCT04231760 — The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD · Phase 1, PHASE2 · not yet recruiting
NCT06649604 — Reducing Pain From Retinal Laser With Vibrational Stimulation · NA · not yet recruiting
NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT06920914 — Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06241209 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alberta
Last refreshed: 16 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06241209.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing